Viewing Study NCT04067492


Ignite Creation Date: 2025-12-24 @ 3:31 PM
Ignite Modification Date: 2026-01-16 @ 4:17 AM
Study NCT ID: NCT04067492
Status: TERMINATED
Last Update Posted: 2022-07-25
First Post: 2019-08-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack
Sponsor: R-Pharm
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gout Attack View
Keywords:

Keywords

Keyword Brief Keyword Text View
None hyperuricemia View
None acute arthritis View
None gouty arthritis View
None gout View